Literature DB >> 26118712

Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma.

Fatemeh Shidfar, Seyed H Ghaffari1, Gholamreza Tavoosidana, Elham Hosseini, Kamran Alimoghaddam, Ardeshir Ghavamzadeh.   

Abstract

MicroRNAs (miRNAs) have a major role in cancer pathogenesis, cells growth and apoptosis. We studied the dysregulation of miRNAs after the induction of apoptosis by 4 μM dose of ATO in glioblastoma cell line, U87. The anticancer effect of ATO was verified using MTT, BrdU cell proliferation assay and flow cytometric analysis. Differential expressions of 88 cancer-related miRNAs were analyzed by real-time reverse transcription PCR using miRNA PCR cancer-array system. The fold changes of miRNAs were calculated by comparing the results of treated to untreated control. Among the 88 cancer-related miRNAs, 2-fold upregulation was detected in 26 miRNAs and downregulation in 10 miRNAs compared to the control. The role of some of the miRNAs with significant changes was investigated by searching the literature and studying their roles in apoptosis, cell cycle and in various cellular signalling pathways. Our results showed that ATO modified the expression of a significant number of cancer-related miRNAs in glioblastoma cell line; most of these especially the upregulated miRNAs, were known as tumor suppressors with extensive roles in cancer associated processes and pathways. This study supports the mediatory role of miRNAs in anticancer effect of ATO.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26118712     DOI: 10.2174/1871520615666150629100752

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  3 in total

1.  The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).

Authors:  Ali Zekri; Yashar Mesbahi; Elham Boustanipour; Zahra Sadr; Seyed H Ghaffari
Journal:  J Mol Neurosci       Date:  2018-07-26       Impact factor: 3.444

2.  Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells.

Authors:  Ying Shi; Tong Cao; Hua Huang; Chaoqun Lian; Ying Yang; Zhiwei Wang; Jia Ma; Jun Xia
Journal:  Cell Cycle       Date:  2017-11-20       Impact factor: 4.534

Review 3.  Arsenic trioxide as a novel anti-glioma drug: a review.

Authors:  Yi Fang; Zhen Zhang
Journal:  Cell Mol Biol Lett       Date:  2020-09-24       Impact factor: 5.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.